X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cipla Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla Quarterly Results   (CIPL)

Here are the latest quarterly results of Cipla. For more details, see the Cipla financial fact sheet and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Cipla Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m37,51036,47235,82035,25140,82439,13836,98039,390 
Other income Rs m2721,5352281,5141,1335294001,701 
Turnover Rs m37,78338,00736,04836,76441,95739,66837,38041,091 
Expenses Rs m30,70329,69630,75828,78632,78030,95231,41132,126 
Gross profit Rs m6,6346,6675,0536,4658,0338,1784,7937,253 
Depreciation Rs m2,2922,5776,3222,1343,0225,2242,8482,410 
Interest Rs m35259333427942092352351 
Profit before tax Rs m4,2625,031-1,3755,5665,7243,3921,9936,193 
Tax Rs m7191,283-7571,3081,3746424621,737 
Profit after tax Rs m3,5433,748-6184,2584,3502,7501,5314,456 
Gross profit margin %17.718.314.118.319.720.913.018.4 
Effective tax rate %16.925.555.123.524.018.923.228.0 
Net profit margin %9.410.3-1.712.110.77.04.111.3 
Diluted EPS Rs 4.4 4.7 -0.8 5.3 5.4 3.4 1.9 5.5  
Diluted EPS (TTM) Rs 14.2 14.6 12.8 13.6 14.6 13.4 16.0 16.3  
 Subscriber Feature   View     View        
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Cipla 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   PLETHICO PHARMA  ORCHID PHARMA LTD  GSK PHARMA  SUVEN LIFE  NOVARTIS  

Compare CIPLA With:   PLETHICO PHARMA  ORCHID PHARMA LTD  GSK PHARMA  SUVEN LIFE  NOVARTIS  

Compare CIPLA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 383 Points Lower; Realty and Auto Stocks Drag(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Views on news

CIPLA Announces Quarterly Results (1QFY19); Net Profit Up 4.7% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, CIPLA has posted a net profit of Rs 4 bn (up 4.7% YoY). Sales on the other hand came in at Rs 39 bn (up 11.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY18); Net Profit Down 347.8% (Quarterly Result Update)

May 24, 2018 | Updated on May 24, 2018

For the quarter ended March 2018, CIPLA has posted a net profit of Rs 2 bn (down 347.8% YoY). Sales on the other hand came in at Rs 37 bn (up 3.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

This Market Crash could be the Biggest Wealth Creating Opportunity Since 2008(Profit Hunter)

Oct 8, 2018

While widespread fear is the friend of a value investor, serving up bargain purchases; personal fear is an investor's biggest enemy.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Are These Deep Corrections a Buying Signal?(Chart Of The Day)

Oct 5, 2018

The correction has bought many good companies to reasonable valuations. Go against the wisdom of crowd and Buy.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Oct 17, 2018 (Close)

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS